Investigational follicle-stimulating hormone receptor agonists for male infertility therapy

Introduction According to estimates by the World Health Organization, about 17.5% of the adult population – roughly 1 in 6 globally – experience infertility. The causes of male infertility remain poorly understood and have yet to be fully evaluated. Follicle-stimulating hormone (FSH) represents an available and useful therapeutic strategy for the treatment of idiopathic infertility.